Legal Representation
Attorney
Jinggao LI
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 25, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 25, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 30, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 5, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 5, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 30, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 28, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 27, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 27, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 6, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 5, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer
Additional Information
Design Mark
The mark consists of the stylized wording "Dizal" with a backwards "S" shaped design above and Chinese symbols on the right of the wording.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording Dizal has no meaning in a foreign language.
Other
The non-Latin characters in the mark transliterate to "DE ZHE" and this means "enlighten, wise" in English.
Classification
International Classes
005